"We know the devil will be in the detail and there is a huge amount of work ahead in negotiating and defining how we implement the reforms that are so urgently needed," said Medicines Australia chief executive and HTA review reference committee member Liz de Somer. …
Medicines Australia says the 'devil is in the detail' of HTA review options paper
January 29, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Specialised Therapeutics expands partnership with Incyte to include two additional therapies
June 13, 2025 - - Latest News -
New immunisation strategy highlights COVID impact, priority patients and new technologies
June 12, 2025 - - Latest News -
Medicines Australia establishes radiopharmaceuticals working group
June 12, 2025 - - Latest News -
MSD Australia and New Zealand certified a 'Great Place to Work'
June 12, 2025 - - Latest News -
Specialised Therapeutics expands partnership with Incyte to include two additional therapies
June 12, 2025 - - Latest News -
Novo Nordisk partners with Heart of Australia to expand clinical trial access
June 12, 2025 - - Latest News -
Mark Butler starts the process of NDIS pricing reform
June 11, 2025 - - Latest News